Patents by Inventor Zoe Alicia HENLEY

Zoe Alicia HENLEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oxepinopyrazole derivatives as inhibitors of P13-kinase activity
    Patent number: 11555040
    Abstract: The invention is directed to compounds of formula (I), and salts thereof. The compounds are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Grant
    Filed: April 16, 2018
    Date of Patent: January 17, 2023
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Andrew Baxter, Sophie Marie Bertrand, Matthew Campbell, Kenneth David Down, Curt Dale Haffner, Julie Nicole Hamblin, Zoe Alicia Henley, William Henry Miller, Eric Philippe Andre Talbot, Jonathan Andrew Taylor
  • CHEMICAL COMPOUNDS
    Publication number: 20220324875
    Abstract: The invention is directed to compounds of formula (I), and salts thereof. The compounds are inhibitors of kinase activity, in particular PI3-kinase activity.
    Type: Application
    Filed: April 16, 2018
    Publication date: October 13, 2022
    Applicant: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Andrew BAXTER, Sophie Marie BERTRAND, Matthew CAMPBELL, Kenneth David DOWN, Curt Dale HAFFNER, Julie Nicole HAMBLIN, Zoe Alicia HENLEY, William Henry MILLER, Eric Philippe Andre TALBOT, Jonathan Andrew TAYLOR